Do reducing regimens of fluorometholone for paediatric ocular surface disease cause glaucoma? | British Journal of Ophthalmology

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via AAO

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Article info

Clinical science

Original article

Do reducing regimens of fluorometholone for paediatric ocular surface disease cause glaucoma?

Authors

Asimina Mataftsi PubMed articles Google scholar articles
Aman Narang PubMed articles Google scholar articles
Will Moore PubMed articles Google scholar articles
Ken K Nischal PubMed articles Google scholar articles

Correspondence to Dr K K Nischal, Clinical and Academic Department of Ophthalmology, Great Ormond Street Hospital, London, UK; kkn{at}btinternet.com

Citation

Mataftsi A, Narang A, Moore W, et al

Do reducing regimens of fluorometholone for paediatric ocular surface disease cause glaucoma?

British Journal of Ophthalmology 2011;95:1531-1533.

Publication history

Accepted January 2, 2011
First published February 4, 2011.

Online issue publication

December 10, 2016

Article Versions

Previous version (22 March 2016).
You are viewing the most recent version of this article.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© 2011, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.